Broggini Massimo

Istituto di Ricerche Farmacologiche Mario Negri - Milan / Italy

Others

AD Scientific Index ID: 4696457

Mario Negri Institute for Pharmacological Research

Registration, Add Profile,
Premium Membership

Print Your Certificate

Broggini Massimo's MOST POPULAR ARTICLES

1-) Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial MC Garassino, O Martelli, M Broggini, G Farina, S Veronese, E Rulli, ... The lancet oncology 14 (10), 981-988, 2013 5552013

2-) Epithelial–mesenchymal transition and breast cancer: Role, molecular mechanisms and clinical impact C Foroni, M Broggini, D Generali, G Damia Cancer treatment reviews 38 (6), 689-697, 2012 3252012

3-) Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy T Bertani, F Cutillo, C Zoja, M Broggini, G Remuzzi Kidney Int 30 (4), 488-496, 1986 2811986

4-) Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743M Minuzzo, S Marchini, M Broggini, G Faircloth, M D\\\'Incalci, R MantovaniProceedings of the National Academy of Sciences 97 (12), 6780, 20002812000

5-) Platinum resistance in ovarian cancer: role of DNA repairG Damia, M BrogginiCancers 11 (1), 119, 20192712019

ARTICLES

Add your articles